Cara Therapeutic
Biotechnology
Healthcare
CARA
54.84 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.82
52 week high
6.12
high
4.98
52 week low
3.00
low
4.71
growth
55.56 %
previous Close
4.85
P/E ratio
market cap
1.62 M
div yield
0
usd
Sep 2024
qoq
revenue
2.56 M
157.92 %
net incoming
-12.48 M
37.67 %
eps
0.00 %
68.08 %
eps surprise
51.80 %
net profit margin
-488.11 %
1531.00 %
operating incoming
-5.99 M
63.07 %
net change in cash
-10.68 M
-576.06 %
cash on hand
37.06 M
-24.73 %
cost of revenue
0.00 %
top top